- Home
- SHEL vs AZN Comparison
SHEL vs AZN Comparison
Compare SHEL & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHEL
- AZN
- Stock Information
- Founded
- SHEL 1907
- AZN 1992
- Country
- SHEL United Kingdom
- AZN United Kingdom
- Employees
- SHEL N/A
- AZN N/A
- Industry
- SHEL Oil & Gas Production
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- SHEL Energy
- AZN Health Care
- Exchange
- SHEL Nasdaq
- AZN Nasdaq
- Market Cap
- SHEL 199.9B
- AZN 234.5B
- IPO Year
- SHEL N/A
- AZN 1993
- Fundamental
- Price
- SHEL $66.33
- AZN $63.39
- Analyst Decision
- SHEL Buy
- AZN Buy
- Analyst Count
- SHEL 5
- AZN 9
- Target Price
- SHEL $83.00
- AZN $88.80
- AVG Volume (30 Days)
- SHEL 5.0M
- AZN 7.5M
- Earning Date
- SHEL 10-31-2024
- AZN 11-12-2024
- Dividend Yield
- SHEL 4.14%
- AZN 2.34%
- EPS Growth
- SHEL N/A
- AZN 9.79
- EPS
- SHEL 2.42
- AZN 4.15
- Revenue
- SHEL $296,762,000,000.00
- AZN $51,206,000,000.00
- Revenue This Year
- SHEL $4.86
- AZN $17.69
- Revenue Next Year
- SHEL N/A
- AZN $7.95
- P/E Ratio
- SHEL $12.86
- AZN $29.92
- Revenue Growth
- SHEL N/A
- AZN 13.81
- 52 Week Low
- SHEL $60.34
- AZN $60.47
- 52 Week High
- SHEL $74.61
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- SHEL 46.04
- AZN 20.49
- Support Level
- SHEL $65.27
- AZN $62.94
- Resistance Level
- SHEL $66.12
- AZN $65.98
- Average True Range (ATR)
- SHEL 0.88
- AZN 1.39
- MACD
- SHEL -0.10
- AZN -0.35
- Stochastic Oscillator
- SHEL 42.73
- AZN 5.68
About SHEL Shell PLC (each representing two (2))
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 1.5 million barrels of liquids and 7.3 billion cubic feet of natural gas per day. At end-2023, reserves stood at 9.6 billion barrels of oil equivalent, 49% of which, consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.6 mmb/d located in the Americas, Asia, Africa, and Europe and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.